BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

889 related articles for article (PubMed ID: 27959960)

  • 21. Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013-2016.
    Tan Y; Su B; Shu W; Cai X; Kuang S; Kuang H; Liu J; Pang Y
    BMC Pulm Med; 2018 Nov; 18(1):168. PubMed ID: 30413193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.
    Cadelis G; Ducrot R; Bourdin A; Rastogi N
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005841. PubMed ID: 28787454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary infection caused by nontuberculous mycobacteria in a medical center in Taiwan, 2005-2008.
    Chen CY; Chen HY; Chou CH; Huang CT; Lai CC; Hsueh PR
    Diagn Microbiol Infect Dis; 2012 Jan; 72(1):47-51. PubMed ID: 22015322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014.
    Adjemian J; Olivier KN; Prevots DR
    Ann Am Thorac Soc; 2018 Jul; 15(7):817-826. PubMed ID: 29897781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphadenitis caused by non-tuberculous mycobacteria in a university hospital in Taiwan: predominance of rapidly growing mycobacteria and high recurrence rate.
    Ding LW; Lai CC; Lee LN; Huang LM; Hsueh PR
    J Formos Med Assoc; 2005 Dec; 104(12):897-904. PubMed ID: 16607446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013.
    Morimoto K; Hasegawa N; Izumi K; Namkoong H; Uchimura K; Yoshiyama T; Hoshino Y; Kurashima A; Sokunaga J; Shibuya S; Shimojima M; Ato M; Mitarai S
    Ann Am Thorac Soc; 2017 Jan; 14(1):49-56. PubMed ID: 27788025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nontuberculous Mycobacteria in Children: A Focus on Bloodstream Infections.
    Al Yazidi LS; Marais BJ; Hazelton B; Outhred A; Kesson A
    Pediatr Infect Dis J; 2017 Apr; 36(4):374-378. PubMed ID: 27918379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extrapulmonary Nontuberculous Mycobacterial Disease Surveillance - Oregon, 2014-2016.
    Shih DC; Cassidy PM; Perkins KM; Crist MB; Cieslak PR; Leman RL
    MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(31):854-857. PubMed ID: 30091968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nontuberculosis mycobacterial infections at a specialized tuberculosis treatment centre in the Republic of Korea.
    Yoon HJ; Choi HY; Ki M
    BMC Infect Dis; 2017 Jun; 17(1):432. PubMed ID: 28619015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London.
    Davies BS; Roberts CH; Kaul S; Klein JL; Milburn HJ
    Scand J Infect Dis; 2012 Nov; 44(11):815-9. PubMed ID: 23078529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency and clinical significance of respiratory isolates of non-tuberculous mycobacteria in Riyadh, Saudi Arabia.
    Al-Harbi A; Al-Jahdali H; Al-Johani S; Baharoon S; Bin Salih S; Khan M
    Clin Respir J; 2016 Mar; 10(2):198-203. PubMed ID: 25130951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary versus Nonpulmonary Nontuberculous Mycobacteria, Ontario, Canada.
    Brode SK; Marchand-Austin A; Jamieson FB; Marras TK
    Emerg Infect Dis; 2017 Nov; 23(11):1898-1901. PubMed ID: 29048292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic treatment for nontuberculous mycobacterial lung disease.
    Kang YA; Koh WJ
    Expert Rev Respir Med; 2016; 10(5):557-68. PubMed ID: 26967761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase in non-tuberculous mycobacteria isolated from humans in Tuscany, Italy, from 2004 to 2014.
    Rindi L; Garzelli C
    BMC Infect Dis; 2016 Feb; 16():44. PubMed ID: 26831721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and risk factors of pulmonary nontuberculous mycobacterial infections in the Zhejiang Province of China.
    Xu J; Li P; Zheng S; Shu W; Pang Y
    Epidemiol Infect; 2019 Sep; 147():e269. PubMed ID: 31506134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey.
    O'Brien RJ; Geiter LJ; Snider DE
    Am Rev Respir Dis; 1987 May; 135(5):1007-14. PubMed ID: 3579001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycobacterium xenopi, Mycobacterium fortuitum, Mycobacterium kansasii, and other nontuberculous mycobacteria in an area of endemicity for AIDS.
    Shafer RW; Sierra MF
    Clin Infect Dis; 1992 Jul; 15(1):161-2. PubMed ID: 1617056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on the epidemiology of pulmonary nontuberculous mycobacterial infections.
    Kendall BA; Winthrop KL
    Semin Respir Crit Care Med; 2013 Feb; 34(1):87-94. PubMed ID: 23460008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Non-Tuberculosis Mycobacteria by Line Probe Assay and Determination of Drug Resistance Patterns of Isolates in Iranian Patients.
    Karami-Zarandi M; Bahador A; Gizaw Feysia S; Kardan-Yamchi J; Hasan-Nejad M; Mosavari N; Feizabadi MM
    Arch Razi Inst; 2019 Dec; 74(4):375-384. PubMed ID: 31939254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of nontuberculous mycobacterial infections.
    van Ingen J
    Semin Respir Crit Care Med; 2013 Feb; 34(1):103-9. PubMed ID: 23460010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.